Latest Articles

Publication Date
Clinicopathological Characteristics and Oncologic Outcomes of Endometrioid Ovarian Carcinoma: A Retrospective Study from a Tertiary Cancer Centre.

Background/Objectives: To evaluate the clinicopathological features, treatment, and survival outcomes and to identify independent prognosticators for recurrence and mortality in patients with endometrioid ovarian cancer. Methods: The medical records of …

Published: Sept. 28, 2025, midnight
PT Health Watch: What to know about Endometriosis, pain beyond menstruation - Premium Times Nigeria

PT Health Watch: What to know about Endometriosis, pain beyond menstruation Premium Times Nigeria

Published: Sept. 27, 2025, 8:17 p.m.
Adenomyosis: 'The pain was so agonizing, I walked with a stick' - BBC

Adenomyosis: 'The pain was so agonizing, I walked with a stick' BBC

Published: Sept. 27, 2025, 6:19 a.m.
Angen codi ymwybyddiaeth am y peryglon i fenywod beichiog ag adenomyosis - BBC

Angen codi ymwybyddiaeth am y peryglon i fenywod beichiog ag adenomyosis BBC

Published: Sept. 27, 2025, 6:05 a.m.
Analysis of the characteristics of Endometrial Fluid Samples in Recurrent Pregnancy Loss Patients based on 16S rRNA gene sequencing technology - Frontiers

Analysis of the characteristics of Endometrial Fluid Samples in Recurrent Pregnancy Loss Patients based on 16S rRNA gene sequencing technology Frontiers

Published: Sept. 27, 2025, 3:12 a.m.
What causes endometriosis? Scientists are closer to finding out - WRVO Public Media

What causes endometriosis? Scientists are closer to finding out WRVO Public Media

Published: Sept. 26, 2025, 1:22 p.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com Australia

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com Australia

Published: Sept. 26, 2025, 11:03 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com - Investing.com South Africa

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug By Investing.com Investing.com South Africa

Published: Sept. 26, 2025, 10:56 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com India

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com India

Published: Sept. 26, 2025, 10:48 a.m.
Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug - Investing.com

Ananda Pharma ends epilepsy trials, shifts focus to endometriosis drug Investing.com

Published: Sept. 26, 2025, 10:25 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!